T 1474/23 (ligand binding assay/REGENERON PHARMACEUTICALS) of 15.05.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T147423.20250515
- Date of decision
- 15 May 2025
- Case number
- T 1474/23
- Petition for review of
- -
- Application number
- 14799930.4
- IPC class
- G01N 33/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Competitive ligand binding assay for detecting neutralizing antibodies
- Applicant name
- Regeneron Pharmaceuticals, Inc.
- Opponent name
- Maiwald GmbH
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be adapted:
Claims:
No. 1 and 2 of auxiliary request 34 filed under cover of a letter dated 12 April 2025.